The Research and Development team at Alumis focuses on creating targeted therapies for patients with immune-mediated diseases. They leverage powerful data analytics to identify precise treatment targets, develop suitable molecules, and optimize clinical outcomes. This multifaceted approach integrates drug development stages from discovery to clinical trials, aiming to produce innovative solutions that alleviate disease impacts without severe side effects. The team comprises experts in scientific research, preclinical and clinical development, and technical operations, working collectively to transform patient lives.
David M Goldstein
Chief Scientific Officer
Jeff Douglas
Svp, Head Of Development Opera...
Jörn Drappa
Chief Medical Officer
Ken Brameld
Fellow, Head Of Discovery
Kolbot By
SVP Technical Operations
Mark Bradley
Chief Development Officer
Mera Tilley
Vp, Head Of Genetics
Michael Gameng
Director, R&d Business Partner
Pedro Corpuz
Director Of Biomarker Operatio...
Philip Nunn
Senior Vice President Preclini...
Roman Rubio
Svp, Head Of Clinical Developm...
Tim Owens
Svp, Head Of Research
Vince Barella
Director, Research And Develop...
View all